Parry, Joshua
Hwang, Jiho
Stahel, Cedric F.
Henderson, Corey
Nadeau, Jason
Stacey, Stephen
Beauchamp, Kathryn
Moore, Ernest E.
Stahel, Philip F.
Funding for this research was provided by:
Stryker
Article History
Received: 11 October 2019
Accepted: 18 May 2020
First Online: 25 May 2020
Compliance with ethical standards
:
: P.F.S. is the recipient of a peer-reviewed research grant by Stryker Corporation (Kalamazoo, MI) for this project, and the co-inventor of a United States patent No. 11,441,828 entitled: <i>“Inhibition of the alternative complement pathway for treatment of traumatic brain injury, spinal cord injury, and related conditions.”</i> The other authors declare no conflict of interest related to this project.
: The study protocol was approved by the Colorado Multiple Institutional Review Board (COMIRB) #10-0638. The IRB protocol allowed a waiver of consent due to minimal risk.